Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Adnavance Technologies Inc.

http://www.adnavance.com

Latest From Adnavance Technologies Inc.

Adnavance Technologies Inc.

Even though mortality rates double each day an MRSA infection remains untreated, most hospitals have to outsource diagnostics test to off-site labs, losing precious treatment time. Adnavance Technologies hopes to change this. The company's ADNAstat amplification-free technology enalbes rapid detection of MRSA DNA on-site at any hospital.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
UsernamePublicRestriction

Register